Table 3. Model-Estimated Rate of Change From Index Visit to 12 Months After Index Visit in Individual Modifiable CV Risk Factors and Obesogenic Medication Use Among Patients in CDS Clinics Relative to Control Clinics.

Characteristic	Risk ratio or difference in difference (95% CI)^a^,^b
Characteristic	All	Site A	Site B	Site C
Quit smoking^a	1.11 (0.92 to 1.33)	1.19 (0.91 to 1.55)	1.04 (0.77 to 1.41)	1.09 (0.48 to 2.44)
Body mass index^b	0.07 (0.01 to 0.13)	0.09 (0.01 to 0.17)	0.04 (−0.08 to 0.15)	0.19 (−0.06 to 0.44)
Low-density lipoprotein cholesterol^b	−0.92 (−4.65 to 2.80)	−2.96 (−7.90 to 1.99)	4.47 (−2.70 to 11.63)	−4.86 (−22.94 to 13.22)
Systolic blood pressure^b	1.03 (−1.04 to 3.09)	−0.26 (−3.29 to 2.77)	3.64 (−0.30 to 7.58)	−1.65 (−8.25 to 4.96)
Hemoglobin A_1c^b	−0.04 (−0.13 to 0.05)	−0.03 (−0.15 to 0.09)	−0.06 (−0.23 to 0.11)	−0.11 (−0.46 to 0.24)
Obesogenic SMI medication discontinuation^a	1.02 (0.81 to 1.29)	1.03 (0.76 to 1.39)	0.92 (0.58 to 1.47)	1.15 (0.56 to 2.38)

Abbreviations: CDS, clinical decision support; CV, cardiovascular; SMI, serious mental illness.

^{^a}

Risk ratio (95% CI), adjusted for sex, age at index visit, log (year of index visit to last visit), site, and balancing factors.

^{^b}

Difference in difference (95% CI), adjusted for sex, age at index visit, index visit value, site, and balancing factors.